tiprankstipranks
TipRanksTop Financial ExpertsInsidersMPM BIOVENTURES 2018, L.P.

MPM BIOVENTURES 2018, L.P. Insider Profile

4 Followers
MPM BIOVENTURES 2018, L.P., Ten Percent Owner at Dyne Therapeutics, holds 91.08K shares in Dyne Therapeutics (Ticker: DYN).
tipranks
MPM BIOVENTURES 2018, L.P.

MPM BIOVENTURES 2018, L.P.
Dyne Therapeutics (DYN)
Ten Percent Owner

Not Ranked
MPM BIOVENTURES 2018, L.P. has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$2M
100.00%
A breakdown of MPM BIOVENTURES 2018, L.P.'s holdings

Insider Roles

Dyne Therapeutics
(DYN)
Ten Percent Owner
Roles that MPM BIOVENTURES 2018, L.P. holds in companies

Most Profitable Insider Trade

Currently, no data available
The most profitable trade made by MPM BIOVENTURES 2018, L.P.

MPM BIOVENTURES 2018, L.P.'s Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Dyne Therapeutics
Sep 23, 2020
Ten Percent Owner
Uninformative Buy
$2.03M
MPM BIOVENTURES 2018, L.P. has not reported any informative transactions for DYN, therefore, performance cannot be measured.
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Sep 23, 2020
Uninformative Buy
$0.00
-
$0.00
List of latest transactions for each holding click on a transaction to see MPM BIOVENTURES 2018, L.P.'s performance on stock

MPM BIOVENTURES 2018, L.P. insider profile FAQ

What is the percentage of profitable transactions made by MPM BIOVENTURES 2018, L.P.?
The percentage of profitable transactions made by MPM BIOVENTURES 2018, L.P. is ―.
    What is the average return per transaction made by MPM BIOVENTURES 2018, L.P.?
    The average return per transaction made by MPM BIOVENTURES 2018, L.P. is ―.
      What stocks does MPM BIOVENTURES 2018, L.P. hold?
      MPM BIOVENTURES 2018, L.P. holds: DYN stocks.
        What was MPM BIOVENTURES 2018, L.P.’s latest transaction?
        MPM BIOVENTURES 2018, L.P. latest transaction was an Uninformative Buy of ―.
          What was MPM BIOVENTURES 2018, L.P.'s most profitable transaction?
          MPM BIOVENTURES 2018, L.P.’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
            What is MPM BIOVENTURES 2018, L.P.'s role in Dyne Therapeutics?
            MPM BIOVENTURES 2018, L.P.'s role in Dyne Therapeutics is Ten Percent Owner.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.